On the other hand, it is noteworthy that resistance to anticancer chemotherapy occurs in part because the bone marrow environment promotes cell adhesion-mediated drug resistance in leukemia cells and triggers pro-survival signaling (e.g., the PI3K/AKT pathway) that allows leukemia cells to withstand chemotherapy. Here, AKT1 is linked to leukemia.